Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dennis, Swearingen"'
Autor:
Ting Feng, David P. Noren, Chaitanya Kulkarni, Sara Mariani, Claire Zhao, Erina Ghosh, Dennis Swearingen, Joseph Frassica, Daniel McFarlane, Bryan Conroy
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundHealthcare-associated infection (HAI) remains a significant risk for hospitalized patients and a challenging burden for the healthcare system. This study presents a clinical decision support tool that can be used in clinical workflows to pr
Externí odkaz:
https://doaj.org/article/5f13ba68820046e9a5565f8abe95ff9b
Autor:
Christian Bime, Ying Wang, Gordon Carr, Dennis Swearingen, Sherri Kou, Pam Thompson, Vinita Kusupati, Sairam Parthasarathy
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
ObjectivesThis study aimed to investigate COVID-19-related disparities in clinical presentation and patient outcomes in hospitalized Native American individuals.MethodsThe study was performed within 30 hospitals of the Banner Health system in the Sou
Externí odkaz:
https://doaj.org/article/7ff2b65a3f03466eae98dfb2eaf20c42
Autor:
Yale Chang, Corneliu Antonescu, Shreyas Ravindranath, Junzi Dong, Mingyu Lu, Francesco Vicario, Lisa Wondrely, Pam Thompson, Dennis Swearingen, Deepak Acharya
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Cardiogenic shock (CS) is a severe condition with in-hospital mortality of up to 50%. Patients who develop CS may have previous cardiac history, but that may not always be the case, adding to the challenges in optimally identifying and managing these
Externí odkaz:
https://doaj.org/article/ced4908440ad45bc8b2a27b393a6d524
Autor:
Mark Forman, John Palcza, Jack Tseng, Julie A. Stone, Brittany Walker, Dennis Swearingen, Matthew D. Troyer, Marissa F. Dockendorf
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 5, Pp 545-555 (2019)
β‐site amyloid precursor protein‐cleaving enzyme 1 (BACE1) is required for the production of β‐amyloid peptides, which are implicated in the etiology of Alzheimer's disease. The safety and pharmacokinetics of the BACE1 inhibitor verubecestat
Externí odkaz:
https://doaj.org/article/d5a82e2a471d464587738eee563b31d1
Publikováno v:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2022
In the hospital setting, a small percentage of recurrent frequent patients contribute to a disproportional amount of healthcare resource utilization. Moreover, in many of these cases, patient outcomes can be greatly improved by reducing re-occurring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11aa368e8a24001e5282f95ede433a64
https://pubmed.ncbi.nlm.nih.gov/36086533
https://pubmed.ncbi.nlm.nih.gov/36086533
Autor:
Christine Fandozzi, Deborah Panebianco, Luzelena Caro, Dennis Wolford, Zifang Guo, Iain P. Fraser, Dennis Swearingen, Vanessa Levine, Hwa-Ping Feng, Thomayant Prueksaritanont, Joan R. Butterton, Marian Iwamoto, Wendy W. Yeh
Publikováno v:
Clinical Drug Investigation. 41:133-147
Many people infected with hepatitis C virus have comorbidities, including hypercholesterolemia, that are treated with statins. In this study, we evaluated the drug–drug interaction potential of the hepatitis C virus inhibitors elbasvir (EBR) and gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ebcf0ed8c8b4c9cc92692ec75038ce5
https://doi.org/10.1007/s40261-020-00974-8
https://doi.org/10.1007/s40261-020-00974-8
Publikováno v:
Drugs in Context, Pp 1-10 (2013)
A Phase I, double-blind, randomized, crossover study in healthy males (N=106) was conducted between March 21, 2004, and May 17, 2004, to determine the magnitude and duration of the hemodynamic interaction of avanafil (a phosphodiesterase type-5 inhib
Externí odkaz:
https://doaj.org/article/5ec210d9db4146afbcb6d0dad8ef710e
Publikováno v:
Clinical Pharmacology in Drug Development
Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, is approved (United States and European Union; Sunosi) to treat excessive daytime sleepiness associated with narcolepsy (75‐150 mg/day) or obstructive sleep apnea (37.5‐150 mg/day).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::647c84269521b5c6d25b7cf73fe19452
http://europepmc.org/articles/PMC8048583
http://europepmc.org/articles/PMC8048583
Autor:
Corneliu Antonescu, Pam Thompson, Lisa Wondrely, J David Cowden, Dennis Swearingen, Shreyas Ravindranath, Kristen Tgavalekos, Erina Ghosh, Xu Minnan, David P. Noren, Gregory Boverman
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 19
Journal of Clinical Medicine, Vol 10, Iss 4605, p 4605 (2021)
Volume 10
Issue 19
Journal of Clinical Medicine, Vol 10, Iss 4605, p 4605 (2021)
Coronavirus Disease 2019 (COVID-19) is an international health crisis. In this article, we report on patient characteristics associated with care transitions of: 1) hospital admission from the emergency department (ED) and 2) escalation to the intens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059f12def4c7928376728390089a82d3
http://europepmc.org/articles/PMC8509460
http://europepmc.org/articles/PMC8509460
Autor:
Luzelena, Caro, Thomayant, Prueksaritanont, Christine M, Fandozzi, Hwa-Ping, Feng, Zifang, Guo, Dennis, Wolford, Deborah, Panebianco, Iain P, Fraser, Vanessa, Levine, Dennis, Swearingen, Joan R, Butterton, Marian, Iwamoto, Wendy W, Yeh
Publikováno v:
Clinical drug investigation. 41(2)
Many people infected with hepatitis C virus have comorbidities, including hypercholesterolemia, that are treated with statins. In this study, we evaluated the drug-drug interaction potential of the hepatitis C virus inhibitors elbasvir (EBR) and graz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b418fcdc4e7326a59183564659736b7
https://pubmed.ncbi.nlm.nih.gov/33527237
https://pubmed.ncbi.nlm.nih.gov/33527237